483 Ipsen Biopharm Mar 2002

483 Ipsen Biopharm Mar 2002

Jacqueline Diaz Albert FDA, Omotunde Osunsanmi FDA$119.00 - Available Now

FDA investigators audited the Ipsen Biopharm - Wrexham, United Kingdom facility and issued inspectional observations (via FDA 483) on 21 Mar 2002.

Product details

  • Category: Biologics
  • Inspection end: 21 Mar 2002
  • Location: Wrexham, United Kingdom
  • FEI: 1000346340
Add To Cart